Sinopharm
1099.HK
S$3.19
Share price
-1.32%
Change (1 day)
1.02%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Sinopharm (1099.HK) - Total assets
Total assets on the balance sheet as of December 2024 : S$69.30 Billion
According to Sinopharm's latest financial reports the company's total assets are S$69.30 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Sinopharm - Total assets on balance sheet (from 2008 to 2024)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | S$71.63 B | 1.03% |
| 2022-12-31 | S$70.90 B | -0.36% |
| 2021-12-31 | S$71.16 B | 12.72% |
| 2020-12-31 | S$63.13 B | 21.2% |
| 2019-12-31 | S$52.08 B | 11.21% |
| 2018-12-31 | S$46.83 B | 19.47% |
| 2017-12-31 | S$39.20 B | 19.26% |
| 2016-12-31 | S$32.87 B | 8.02% |
| 2015-12-31 | S$30.43 B | 10.84% |
| 2014-12-31 | S$27.45 B | 24.36% |
| 2013-12-31 | S$22.07 B | 38.74% |
| 2012-12-31 | S$15.91 B | 14.19% |
| 2011-12-31 | S$13.93 B | 70.26% |
| 2010-12-31 | S$8.18 B | 21.98% |
| 2009-12-31 | S$6.70 B | 98.25% |
| 2008-12-31 | S$3.38 B | 20.08% |
| 2007-12-31 | S$2.81 B | 23.8% |
| 2006-12-31 | S$2.27 B |